treatment burden

treatment burden

The deterioration in a patient's health that may be caused by exposure to medications, radiation therapy, surgery, or other forms of therapy.
References in periodicals archive ?
ACP recommended that clinicians should personalise goals for blood sugar control in patients with type 2 diabetes based on a discussion of benefits and harms of drug therapy, patients' preferences, patients' general health and life expectancy, treatment burden, and costs of care.
Besides minimizing the impact of this life-long disease, newer treatment options can reduce treatment burden and allow patients to live more normal, active lifestyles thereby making a significant difference in their lives.
Although medications are necessary for adequate symptom control, the treatment burden can become over whelming for the caregiver and child, and can negatively impact quality of life (Ziaian et al.
Survival for this fast-growing, high-grade tumour is currently less than 10% but scientists hope a successful trial could see the drug being combined with other traditional therapies in order to reduce the treatment burden and improve survival for patients.
This study provides an important alternative, time-saving treatment for the CF patient that does not add to the treatment burden of CF patients.
As the only therapeutic candidate specifically targeting the eradication of bacterial persisters, EBX-001 has unique potential to treat these persistent infections and reduce morbidity, mortality and the treatment burden to patients, their families and health care delivery systems.
While the observation period was too limited to determine the impact on the diagnosis of metastatic prostate cancer, which Is associated with a high treatment burden, decrease in quality of life, and Increased mortality, the authors did observe a small upward trend in diagnoses of nonlocalized disease.
Hypofractionated WBI increases convenience, reduces treatment burden, and lowers health-care costs while offering similar cancer control to conventional WBI, according to a study by Justin E.
The benefit in patients with a high volume of metastatic disease is clear and justifies the treatment burden.
Any reduction of the treatment burden of anti-VEGF therapies would be a major advance in the treatment of neovascular AMD, said Jay S.
Full browser ?